Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Sinicrope · SciRah

Researcher profile · Semantic Scholar

F. Sinicrope

Share profile

F. Sinicrope — researcher profile on SciRah

h-index: 74
Works: 382
Citations: 23K

Most-cited papers

Tumor Mutational Burden (TMB) as a Predictive Biomarker in Solid Tumors
D. Sha, Zhao-Hui Jin, J. Budczies, K. Kluck +2 more
2020Cancer Discovery641 citations Open access
Semantic Scholar
Increasing Incidence of Early-Onset Colorectal Cancer.
F. Sinicrope
2022New England Journal of Medicine409 citations
Semantic Scholar
Lynch Syndrome–Associated Colorectal Cancer
F. Sinicrope
2018New England Journal of Medicine235 citations
Semantic Scholar
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.
R. Cohen, J. Taieb, J. Fiskum, G. Yothers +17 more
2020Journal of Clinical Oncology140 citations Open access
Semantic Scholar
Mismatch Repair-Deficient Colorectal Cancer: Building on Checkpoint Blockade.
Zhao-Hui Jin, F. Sinicrope
2022Journal of Clinical Oncology125 citations Open access
Semantic Scholar
Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer
P. Zhang, H. Kawakami, Weizhen Liu, Xiangyu Zeng +4 more
2017Molecular Cancer Research107 citations Open access
Semantic Scholar
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
J. Taieb, Qian D. Shi, L. Pederson, S. Alberts +11 more
2019Annals of Oncology82 citations Open access
Semantic Scholar
Inter-tumoral heterogeneity of CD3+ and CD8+ T-cell densities in the microenvironment of DNA mismatch repair-deficient colon cancers: implications for prognosis
H. Yoon, Q. Shi, Erica N. Heying, A. Muranyi +10 more
2018Clinical Cancer Research79 citations Open access
Semantic Scholar
BRAFV600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
Daofu Feng, B. Qin, Krishnendu Pal, Lei Sun +6 more
2019Oncogene77 citations Open access
Semantic Scholar
Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer
Zhao-Hui Jin, F. Sinicrope
2021Cancers55 citations Open access
Semantic Scholar
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
C. Burke, E. Dekker, P. Lynch, N. Samadder +27 more
2020New England Journal of Medicine53 citations Open access
Semantic Scholar
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer: A Review.
O. Emiloju, F. Sinicrope
2023JAMA Oncology51 citations
Semantic Scholar
Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502).
F. Sinicrope, F. Ou, T. Zemla, A. Nixon +12 more
2019Journal of Clinical Oncology50 citations
Semantic Scholar
Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
B. Saberzadeh-Ardestani, J. Jones, J. Hubbard, R. McWilliams +6 more
2023JAMA Network Open49 citations Open access
Semantic Scholar
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
Wu Jiang, M. Cai, Shi-Yong Li, Jin-Xin Bei +28 more
2019International Journal of Cancer48 citations Open access
Semantic Scholar
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials
J. Taieb, F. Sinicrope, L. Pederson, S. Lonardi +12 more
2023Annals of Oncology44 citations Open access
Semantic Scholar
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
F. Sinicrope, Q. Shi, F. Hermitte, T. Zemla +10 more
2020JNCI Cancer Spectrum44 citations Open access
Semantic Scholar
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
J. Taieb, Q. Shi, L. Pederson, S. Alberts +11 more
201941 citations Open access
Semantic Scholar
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
Zhao-Hui Jin, J. Dixon, J. Fiskum, Hiral D. Parekh +26 more
2021Journal of the National Cancer Institute39 citations Open access
Semantic Scholar
Ferroptosis: Biology and Role in Gastrointestinal Disease.
J. Escuder-Rodríguez, D. Liang, X. Jiang, F. Sinicrope
2024Gastroenterology38 citations Open access
Semantic Scholar
Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)
M. Song, F. Ou, T. Zemla, M. Hull +8 more
2019International Journal of Cancer38 citations Open access
Semantic Scholar
Prognostic Variables in Low and High Risk Stage III Colon Cancers Treated in Two Adjuvant Chemotherapy Trials
F. Sinicrope, S. Chakrabarti, P. Laurent-Puig, L. Huebner +11 more
2020European Journal of Cancer35 citations Open access
Semantic Scholar
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
B. Saberzadeh-Ardestani, Jeremy C Jones, R. McWilliams, D. Tougeron +11 more
2023European Journal of Cancer33 citations
Semantic Scholar
Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502).
F. Sinicrope, F. Ou, Q. Shi, A. Nixon +13 more
201732 citations
Semantic Scholar
Association of Tumor-infiltrating Lymphocytes (TILs) with Survival Depends on Primary Tumor Sidedness in Stage III Colon Cancers (NCCTG N0147) [Alliance]
B. Saberzadeh-Ardestani, N. Foster, H. Lee, Q. Shi +3 more
2022Annals of Oncology31 citations Open access
Semantic Scholar
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
C. Gallois, Matteo Landi, J. Taieb, M. Sroussi +18 more
2023Clinical Cancer Research29 citations Open access
Semantic Scholar
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia
F. Sinicrope, T. Viggiano, N. Buttar, L. M. Wong Kee Song +15 more
2021Cancer Prevention Research29 citations Open access
Semantic Scholar
USP10 regulates ZEB1 ubiquitination and protein stability to inhibit ZEB1-mediated colorectal cancer metastasis
Lei Sun, Jia Yu, J. Guinney, B. Qin +1 more
2023Molecular Cancer Research26 citations Open access
Semantic Scholar
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
C. Gallois, Q. Shi, J. Meyers, T. Iveson +20 more
2022Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Intratumoral CD3+ and CD8+ T-Cell Densities in Patients With DNA Mismatch Repair-Deficient Metastatic Colorectal Cancer Receiving Programmed Cell Death-1 Blockade.
S. Chakrabarti, L. Huebner, Heidi D. Finnes, A. Muranyi +6 more
2019JCO Precision Oncology24 citations
Semantic Scholar
Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials.
N. Christou, E. Bergen, C. Canton, K. Le Malicot +10 more
2022European Journal of Cancer21 citations Open access
Semantic Scholar
Immune marker spatial distribution and clinical outcome after PD-1 blockade in mismatch repair-deficient, advanced colorectal carcinomas
B. Saberzadeh-Ardestani, Rondell P. Graham, Sara McMahon, Eze Ahanonu +9 more
2023Clinical Cancer Research16 citations Open access
Semantic Scholar
EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy
F. Gleeson, M. Levy, A. Roden, L. Boardman +3 more
2018Endoscopy International Open16 citations Open access
Semantic Scholar
Physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)
A. Phipps, Q. Shi, T. Zemla, Efrat Dotan +10 more
2018Cancer Epidemiology, Biomarkers and Prevention16 citations Open access
Semantic Scholar
Tumor-Infiltrating Lymphocytes for Prognostic Stratification in Nonmetastatic Colon Cancer-Are We There Yet?
F. Sinicrope, Rondell P. Graham
2021JAMA Oncology15 citations
Semantic Scholar
Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
O. Emiloju, M. Storandt, T. Zemla, Tran Nguyen +10 more
2024JCO Precision Oncology13 citations Open access
Semantic Scholar
Evaluating the Combination of Microsatellite Instability and Mutation in BRAF as Prognostic Factors for Patients With Colorectal Cancer.
F. Sinicrope
2019Clinical Gastroenterology and Hepatology12 citations
Semantic Scholar
Defining colon cancer biomarkers by using deep learning.
Adrian V. Specogna, F. Sinicrope
2020The Lancet11 citations
Semantic Scholar
Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia
Veroushka Ballester, W. Taylor, S. Slettedahl, D. Mahoney +9 more
2020Epigenomics11 citations Open access
Semantic Scholar
Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms
F. Sinicrope, P. Velamala, L. W. K. Song, T. Viggiano +17 more
2019Cancer Prevention Research11 citations
Semantic Scholar
Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer
Lei Sun, Á. Patai, Tara L. Hogenson, M. Fernández-Zapico +2 more
2021Oncogene10 citations
Semantic Scholar
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer
F. Sinicrope, Q. Shi, T. Smyrk, R. Goldberg +10 more
2021JNCI Cancer Spectrum9 citations Open access
Semantic Scholar
Genetic Variant Associated with Survival of Patients with Stage II-III Colon Cancer
K. Penney, B. Banbury, S. Bien, T. Harrison +20 more
2019Clinical Gastroenterology and Hepatology9 citations Open access
Semantic Scholar
Improved risk stratification scheme for mismatch repair proficient stage II colorectal cancers using the digital pathology biomarker QuantCRC
Christina Wu, Reetesh K. Pai, H. Kosiorek, Imon Banerjee +17 more
2024Clinical Cancer Research8 citations Open access
Semantic Scholar
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.
A. Zaanan, Q. Shi, J. Taieb, S. Alberts +13 more
2020JCO Precision Oncology8 citations Open access
Semantic Scholar
Immunoscore to provide prognostic information in low- (T1-3N1) and high-risk (T4 or N2) subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).
F. Sinicrope, Q. Shi, F. Hermitte, Erica N. Heying +9 more
20188 citations
Semantic Scholar
Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal Cancer
G. Pitari, P. Cotzia, Mehboob Ali, R. Birbe +7 more
2018Biomarkers in Cancer8 citations Open access
Semantic Scholar
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.
F. Sinicrope, Qian Shi, A. Catteau, G. Poage +11 more
2022JCO Precision Oncology7 citations Open access
Semantic Scholar
Advances in the therapy of BRAFV600E metastatic colorectal cancer
Zhao-Hui Jin, F. Sinicrope
2019Expert Review of Anticancer Therapy6 citations
Semantic Scholar
913e CLINICAL VALIDATION OF A CELL-FREE DNA BLOOD-BASED TEST FOR COLORECTAL CANCER SCREENING IN AN AVERAGE RISK POPULATION
Daniel Chung, Darrell M. Gray, J. Greenson, Samir Gupta +7 more
2023Gastroenterology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Alberts×17
Invite
S. Alberts — researcher profile on SciRah
Q. Shi×16
Invite
Q. Shi — researcher profile on SciRah
R. Goldberg×13
Invite
R. Goldberg — researcher profile on SciRah
Zhao-Hui Jin×9
Invite
Zhao-Hui Jin — researcher profile on SciRah

×9

Invite

J. Taieb — researcher profile on SciRah

Invite

G. Yothers — researcher profile on SciRah

Invite

S. Lonardi — researcher profile on SciRah

Invite

T. Zemla — researcher profile on SciRah

Invite

T. Smyrk — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah

A. de Gramont×5

Invite

A. de Gramont — researcher profile on SciRah

Invite

R. Kerr — researcher profile on SciRah